Publications:247
Samuel Waxman, MD
About Me
N/A
Language
English
Position
PROFESSOR EMERITUS | Medicine, Hematology and Medical Oncology, PROFESSOR EMERITUS | Oncological Sciences
Publications
Selected Publications
- Overcoming venetoclax resistance through heme-mediated NOXA/cyclin D1/Mcl-1 axis with a novel artemisinin conjugate. Jingyi Zhang, Zhenwei Zhang, Jinghua Liu, Shenglin Luan, Jiqiang Qu, Zi Wu, Yafei Kuang, Ping Gong, Yu Bao, Yuetong Wang, Xiaojing Yan, Samuel Waxman, Linxiang Zhao, Yongkui Jing. Blood advances
- Rational combination of homoharringtonine to selectively target FLT3-ITD acute myeloid leukemia through synthetic lethality. Ying Li, Xiaoxiao Gao, Huimin Zhang, Yang Qiu, Meng Chai, Jinghua Liu, Xiaojing Yan, Samuel Waxman, Jingyi Zhang, Yongkui Jing. Phytomedicine
- Promoting longevity with less cancer: The 2022 International Conference on Aging and Cancer. Yan Cui, Kai Wang, Danli Jiang, Yizhou Jiang, Dawei Shi, James DeGregori, Samuel Waxman, Ruibao Ren. Aging and Cancer
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Waxman has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.